Novel role for PDEF in epithelial cell migration and invasion

被引:69
作者
Gunawardane, RN
Sgroi, DC
Wrobel, CN
Koh, E
Daley, GQ
Brugge, JS
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Pathol Res Unit,Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA
[4] Brown Univ, Providence, RI 02912 USA
关键词
D O I
10.1158/0008-5472.CAN-05-1196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell migration and invasion are two critical cellular processes that are often deregulated during tumorigenesis. To identify factors that contribute to oncogenic progression by stimulating cell migration, we conducted a powerful retroviral based migration screen using an MCF7 cDNA library and the immortalized human breast epithelial cell line MCF-10A. We identified prostate derived Ets factor (PDEF), an Ets transcription factor that is overexpressed in both prostate and breast carcinoma, as a candidate promigratory gene from this screen. Whereas PDEF induced limited motility of MCF-10A cells, coexpression of PDEF with the receptor tyrosine kinases (RTK) ErbR2 and colony-stimulating factor receptor (CSF-IR)/ CSF-1 significantly enhanced MCF-10A motility. Furthermore, cells coexpressing PDEF with either ErbB2 or CSF-IR/CSF-1 induced a dramatic invasive phenotype in three-dimensional cultures. Constitutive activation of the extracellular signal-regulated kinase (ERK) pathway also enhanced PDEF-induced motility and invasion, suggesting that activation of the ERK/ mitogen-activated protein kinase by ErbB2 and CSF-1R/CSF-1 can cooperate with PDEF to promote motility and invasion. Furthermore, PDEF promoted anchorage-independent growth of ErbB2 and CSF-1R/CSF-1-expressing cells. Using laser capture microdissection, we also found that PDEF mRNA is overexpressed in breast tumor epithelia throughout tumor progression. Taken together, these findings suggest that the transcription factor PDEF may play an important role in breast tumorigenesis and that PDEF overexpression may be particularly significant in tumors that exhibit activation of oncogenic RTKs such as ErbB2 and CSF-1R.
引用
收藏
页码:11572 / 11580
页数:9
相关论文
共 38 条
[1]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[2]   The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer [J].
Behrens, P ;
Rothe, M ;
Wellmann, A ;
Krischler, J ;
Wernert, N .
JOURNAL OF PATHOLOGY, 2001, 194 (01) :43-50
[3]   ESX: A structurally unique Ets overexpressed early during human breast tumorigenesis [J].
Chang, CH ;
Scott, GK ;
Kuo, WL ;
Xiong, XH ;
Suzdaltseva, Y ;
Park, JW ;
Sayre, P ;
Erny, K ;
Collins, C ;
Gray, JW ;
Benz, CC .
ONCOGENE, 1997, 14 (13) :1617-1622
[4]   Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures [J].
Debnath, J ;
Muthuswamy, SK ;
Brugge, JS .
METHODS, 2003, 30 (03) :256-268
[5]  
Delannoy-Courdent A, 1998, J CELL SCI, V111, P1521
[6]   The biology of the Ets1 proto-oncogene [J].
Jürgen Dittmer .
Molecular Cancer, 2 (1)
[7]  
Feldman RJ, 2003, CANCER RES, V63, P4626
[8]   Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation [J].
Foos, G ;
García-Ramírez, JJ ;
Galang, CK ;
Hauser, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :18871-18880
[9]   Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness [J].
Foos, G ;
Hauser, CA .
ONCOGENE, 2000, 19 (48) :5507-5516
[10]   Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors [J].
Galang, CK ;
Muller, WJ ;
Foos, G ;
Oshima, RG ;
Hauser, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11281-11292